vs
Side-by-side financial comparison of Dexcom (DXCM) and SERVICE CORP INTERNATIONAL (SCI). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.1× SERVICE CORP INTERNATIONAL). Dexcom runs the higher net margin — 21.2% vs 14.3%, a 6.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 1.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 3.1%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
International Distribution Services Limited is a British company providing postal and courier services. IDS was created in 2013 by the UK government as a new holding company of Royal Mail, and a majority of its shares were then sold on the London Stock Exchange, with the government initially retaining a 30 per cent at the time. As of April 2025, IDS is owned and operated by Czech-based EP Group, owned by Daniel Křetínský.
DXCM vs SCI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $267.3M | $159.4M |
| Gross Margin | 62.9% | 28.0% |
| Operating Margin | 25.6% | 24.8% |
| Net Margin | 21.2% | 14.3% |
| Revenue YoY | 21.6% | 1.7% |
| Net Profit YoY | 153.6% | 5.3% |
| EPS (diluted) | $0.67 | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.0B | $1.1B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $994.2M | $1.0B | ||
| Q2 24 | $1.0B | $1.0B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $159.4M | ||
| Q3 25 | $283.8M | $117.5M | ||
| Q2 25 | $179.8M | $122.9M | ||
| Q1 25 | $105.4M | $142.9M | ||
| Q4 24 | $151.7M | $151.4M | ||
| Q3 24 | $134.6M | $117.8M | ||
| Q2 24 | $143.5M | $118.2M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 28.0% | ||
| Q3 25 | 60.5% | 25.1% | ||
| Q2 25 | 59.5% | 25.5% | ||
| Q1 25 | 56.9% | 27.1% | ||
| Q4 24 | 58.9% | 28.0% | ||
| Q3 24 | 59.7% | 24.9% | ||
| Q2 24 | 62.4% | 24.9% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 24.8% | ||
| Q3 25 | 20.1% | 21.4% | ||
| Q2 25 | 18.4% | 21.1% | ||
| Q1 25 | 12.9% | 23.4% | ||
| Q4 24 | 17.0% | 24.0% | ||
| Q3 24 | 15.3% | 20.9% | ||
| Q2 24 | 15.7% | 21.4% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 14.3% | ||
| Q3 25 | 23.5% | 11.1% | ||
| Q2 25 | 15.5% | 11.5% | ||
| Q1 25 | 10.2% | 13.3% | ||
| Q4 24 | 13.6% | 13.8% | ||
| Q3 24 | 13.5% | 11.6% | ||
| Q2 24 | 14.3% | 11.4% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.13 | ||
| Q3 25 | $0.70 | $0.83 | ||
| Q2 25 | $0.45 | $0.86 | ||
| Q1 25 | $0.27 | $0.98 | ||
| Q4 24 | $0.37 | $1.02 | ||
| Q3 24 | $0.34 | $0.81 | ||
| Q2 24 | $0.35 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $243.6M |
| Total DebtLower is stronger | — | $5.1B |
| Stockholders' EquityBook value | $2.7B | $1.6B |
| Total Assets | $6.3B | $18.7B |
| Debt / EquityLower = less leverage | — | 3.10× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $243.6M | ||
| Q3 25 | $1.8B | $241.3M | ||
| Q2 25 | $1.2B | $255.4M | ||
| Q1 25 | $904.9M | $227.2M | ||
| Q4 24 | $606.1M | $218.8M | ||
| Q3 24 | $621.2M | $185.4M | ||
| Q2 24 | $939.2M | $184.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.1B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | — | $5.0B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | — | $4.8B | ||
| Q3 24 | — | $4.7B | ||
| Q2 24 | — | $4.7B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $1.6B | ||
| Q3 25 | $2.7B | $1.6B | ||
| Q2 25 | $2.6B | $1.6B | ||
| Q1 25 | $2.3B | $1.7B | ||
| Q4 24 | $2.1B | $1.7B | ||
| Q3 24 | $2.0B | $1.6B | ||
| Q2 24 | $2.4B | $1.5B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $18.7B | ||
| Q3 25 | $7.5B | $18.4B | ||
| Q2 25 | $7.3B | $18.0B | ||
| Q1 25 | $6.8B | $17.3B | ||
| Q4 24 | $6.5B | $17.4B | ||
| Q3 24 | $6.4B | $17.4B | ||
| Q2 24 | $6.8B | $16.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.10× | ||
| Q3 25 | — | 3.17× | ||
| Q2 25 | — | 3.19× | ||
| Q1 25 | — | 2.87× | ||
| Q4 24 | — | 2.83× | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | — | 3.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $212.9M |
| Free Cash FlowOCF − Capex | — | $87.2M |
| FCF MarginFCF / Revenue | — | 7.8% |
| Capex IntensityCapex / Revenue | — | 11.3% |
| Cash ConversionOCF / Net Profit | — | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | $554.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $212.9M | ||
| Q3 25 | $659.9M | $252.3M | ||
| Q2 25 | $303.0M | $166.4M | ||
| Q1 25 | $183.8M | $311.1M | ||
| Q4 24 | $301.4M | $264.1M | ||
| Q3 24 | $199.5M | $263.8M | ||
| Q2 24 | $279.4M | $196.9M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $87.2M | ||
| Q3 25 | $579.4M | $150.7M | ||
| Q2 25 | $208.9M | $83.4M | ||
| Q1 25 | $96.8M | $233.0M | ||
| Q4 24 | $176.8M | $151.8M | ||
| Q3 24 | $88.3M | $162.8M | ||
| Q2 24 | $213.3M | $100.8M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 7.8% | ||
| Q3 25 | 47.9% | 14.2% | ||
| Q2 25 | 18.1% | 7.8% | ||
| Q1 25 | 9.3% | 21.7% | ||
| Q4 24 | 15.9% | 13.9% | ||
| Q3 24 | 8.9% | 16.1% | ||
| Q2 24 | 21.2% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 11.3% | ||
| Q3 25 | 6.7% | 9.6% | ||
| Q2 25 | 8.1% | 7.8% | ||
| Q1 25 | 8.4% | 7.3% | ||
| Q4 24 | 11.2% | 10.3% | ||
| Q3 24 | 11.2% | 10.0% | ||
| Q2 24 | 6.6% | 9.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.34× | ||
| Q3 25 | 2.33× | 2.15× | ||
| Q2 25 | 1.69× | 1.35× | ||
| Q1 25 | 1.74× | 2.18× | ||
| Q4 24 | 1.99× | 1.75× | ||
| Q3 24 | 1.48× | 2.24× | ||
| Q2 24 | 1.95× | 1.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
SCI
| Cemetery | $510.9M | 46% |
| Funeral Matured Preneed Revenue | $196.5M | 18% |
| Cemetery Recognized Preneed Merchandise And Service Revenue | $107.4M | 10% |
| Cemetery Atneed Revenue | $104.9M | 9% |
| CA | $56.4M | 5% |
| Funeral Other Revenue | $54.6M | 5% |
| Cemetery Other Revenue | $40.2M | 4% |
| Nonfuneral Home Revenue | $28.1M | 3% |
| Non Funeral Home Preneed Sales Revenue | $22.0M | 2% |
